Response of Tuberculosis to DOTS
Therapy in People Living with HIV/AIDS:
A Prospective Clinical Study
Published: February 1, 2012 | DOI: https://doi.org/10.7860/JCDR/2012/.1839
B. Bhargav Prasad, V.A. Narasimha Raju, P. Jayakar Babu
1. Assistant Professor,Dept.of Chest & TB,
2. Associate Professor, Dept.of Chest & TB,
3. Professor & HOD,Dept.of Chest & TB,
Konaseema Institute of Medical Sciences,
Amalapuram, AP, India.
Correspondence
Dr. B. Bhargav Prasad,
Assistant Professor, Dept.of Chest & TB,
KIMS, Amalapuram-533201.AP
Background:
In the patients with HIV and concomitant tuberculosis (TB), the response to directly observed therapyshort course (DOTS) is variable because of immunosupression, opportunistic infections and intolerance due to drugs including anti-retroviral treatment (ART).
Aim: To study the response of TB to DOTS in immunosupressed patients with HIV.
Material and Methods: Patients who attended our department during 2009-2010 with respiratory symptoms were screened. Study group comprised patients diagnosed with HIV with TB. Study group was further divided in A-CD4 count <150/ cmm, receiving DOTS with ART and B- CD4 count >150/cmm, receiving DOTS alone. Control group comprised patients with TB alone, on DOTS.
Results: Three hundred and forty three patients were diagnosed with TB of which 37, diagnosed with HIV with TB, were included in study (7 with CD4 count <150/cmm, receiving DOTS with ART and 30 with CD4 count >150/cmm, receiving DOTS alone). Control group comprised of 306 patients with TB alone, on DOTS. In the study group, of 7 patients in subgroup A, 2 patients died and 5 patients defaulted. All 30 patients in subgroup B were improved. Improvement was observed in all patients in control group.
Conclusions:Concomitant use of DOTS and ART increase in the incidence of therapy default to DOTS otherwise six months of therapy is enough to cure TB in HIV cases.
[
FULL TEXT ] | [ PDF]